Search results
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Zacks via Yahoo Finance· 2 hours agoHere we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK),...
Merck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma...
Benzinga· 3 days agoThe trial evaluates the investigational coformulation of vibostolimab and Keytruda (pembrolizumab)...
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks via Yahoo Finance· 2 days agoKeytruda development program is also progressing well. The drug is being studied for more than 30...
Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise
MedPage Today· 6 days agoNews, features, and commentary about cancer-related issues
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks via Yahoo Finance· 3 days agoBristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails...
ImmunityBio Advances On the Anktiva Front
Los Angeles Business Journal· 3 days agoImmunityBio Inc., the Culver City-based immunotherapy company founded by billionaire Patrick Soon-Shiong that last month won Food and Drug Administration approval for its ...
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks via Yahoo Finance· 6 days agoIovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for...
Is Eli Lilly Stock A Better Pick Over Amgen?
Forbes· 3 days agoAlso, Eli Lilly has seen a better revenue growth and is more profitable. There is more to the comparison, and in the sections below, we discuss why we...
Is Johnson & Johnson Stock A Better Pick Over Merck?
Forbes· 2 days agoAlthough Merck trades at a higher valuation of 5.5x trailing revenues, compared to 4.2x for J&J, we think that this valuation gap will likely narrow over...
Dow Jones Today: Dow Extends Winning Streak to Eight Days as Major Indexes Gain For Third...
Investopedia· 6 days agoMettler Toledo (MTD) led gains among S&P 500 stocks Friday, soaring 17% following a strong quarterly...